MacroGenics
MGNX
#8794
Rank
โ‚น23.04 B
Marketcap
โ‚น361.77
Share price
5.35%
Change (1 day)
132.98%
Change (1 year)

Earnings for MacroGenics (MGNX)

Earnings in 2026 (TTM): -โ‚น9.9 Billion

According to MacroGenics's latest financial reports the company's current earnings are โ‚น0.16 Billion. In 2025 the company made an earning of -โ‚น7.91 Billion a decrease over its 2024 earnings that were of -โ‚น6.39 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for MacroGenics from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น9.9 Billion25.11%
2025 -โ‚น7.91 Billion23.83%
2024 -โ‚น6.39 Billion628.88%
2023 -โ‚น0.88 Billion-92.44%
2022 -โ‚น11.59 Billion-40.75%
2021 -โ‚น19.56 Billion55.79%
2020 -โ‚น12.55 Billion-14.54%
2019 -โ‚น14.69 Billion-11.46%
2018 -โ‚น16.59 Billion773.65%
2017 -โ‚น1.9 Billion-66.47%
2016 -โ‚น5.67 Billion190.61%
2015 -โ‚น1.95 Billion-47.43%
2014 -โ‚น3.71 Billion14585.78%
2013 -โ‚น25.24 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น668.11 B-6,707.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น3.249 T-32,240.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น995.06 B-9,941.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-โ‚น189.11 Billion 1,770.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น743.85 B-7,457.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.152 T-11,494.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-โ‚น15.56 Billion 53.88%๐Ÿ‡บ๐Ÿ‡ธ USA